Background: To estimate the proportion of elderly patients (>70 years) with breast cancer eligible for an Exclusive\nIntraOperative RadioTherapy (E-IORT) and to evaluate their local recurrence-free survival rate.\nMethods: This retrospective study examining two cohorts focuses on patients over 70 years old: a multi-centric\ncohort of 1411 elderly patients and a mono-centric cohort of 592 elderly patients. All patients underwent conservative\nsurgery followed by external radiotherapy for T0-T3 N0-N1 invasive breast cancer, between 1980 and 2008.\nResults: Within each cohort two groups were identified according to the inclusion criteria of the RIOP trial (R group)\nand TARGIT E study (T group). Each group was divided into two sub-groups, patients eligible (E) or non-eligible (nE) for\nIORT. The population of patients that were eligible in the TARGIT E study but not in the RIOP trial were also studied in\nboth cohorts. The proportion of patients eligible for IORT was calculated, according to the eligibility criteria of each\nstudy. A comparison of the 5-year local or locoregional recurrence-free survival rate between eligible vs non-eligible\npatients was made.\nIn both cohorts, the proportion of patients eligible according to the RIOP trial�s eligibility criteria was 35.4 and 19.3%,\nand according to the TARGIT E study criteria was 60.9 and 45.3%.\nThe 5-year locoregional recurrence-free survival rate was not significantly different between RE and RnE groups, TE and\nTnE groups. In both cohorts RE and (TE-RE) groups were not significantly different.\nConclusions: Our results encourage further necessary studies to define and to extend the eligibility criteria for per\noperative exclusive radiotherapy.
Loading....